581 related articles for article (PubMed ID: 28592714)
21. Advances in Diagnostic Immunohistochemistry for Primary Tumors of the Central Nervous System.
Meredith DM
Adv Anat Pathol; 2020 May; 27(3):206-219. PubMed ID: 30720470
[TBL] [Abstract][Full Text] [Related]
22. Practical implications of integrated glioma classification according to the World Health Organization classification of tumors of the central nervous system 2016.
Malzkorn B; Reifenberger G
Curr Opin Oncol; 2016 Nov; 28(6):494-501. PubMed ID: 27606698
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system.
Gritsch S; Batchelor TT; Gonzalez Castro LN
Cancer; 2022 Jan; 128(1):47-58. PubMed ID: 34633681
[TBL] [Abstract][Full Text] [Related]
24. Glioblastoma: Changing concepts in the WHO CNS5 classification.
Chen J; Han P; Dahiya S
Indian J Pathol Microbiol; 2022 May; 65(Supplement):S24-S32. PubMed ID: 35562131
[TBL] [Abstract][Full Text] [Related]
25. Histopathologic and Molecular Features of Central Nervous System Embryonal Tumors for Integrated Diagnosis Reporting.
Cole BL; Pierson CR
Surg Pathol Clin; 2020 Dec; 13(4):783-800. PubMed ID: 33183733
[TBL] [Abstract][Full Text] [Related]
26. A review of recently described genetic alterations in central nervous system tumors.
Lucas CG; Solomon DA; Perry A
Hum Pathol; 2020 Feb; 96():56-66. PubMed ID: 31678207
[TBL] [Abstract][Full Text] [Related]
27. Diffuse gliomas to date and beyond 2016 WHO Classification of Tumours of the Central Nervous System.
Onizuka H; Masui K; Komori T
Int J Clin Oncol; 2020 Jun; 25(6):997-1003. PubMed ID: 32468200
[TBL] [Abstract][Full Text] [Related]
28. CNS embryonal tumours: WHO 2016 and beyond.
Pickles JC; Hawkins C; Pietsch T; Jacques TS
Neuropathol Appl Neurobiol; 2018 Feb; 44(2):151-162. PubMed ID: 28949028
[TBL] [Abstract][Full Text] [Related]
29. Impact of epidemiological characteristics of supratentorial gliomas in adults brought about by the 2016 world health organization classification of tumors of the central nervous system.
Jiang H; Cui Y; Wang J; Lin S
Oncotarget; 2017 Mar; 8(12):20354-20361. PubMed ID: 27888628
[TBL] [Abstract][Full Text] [Related]
30. DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas.
Paul Y; Mondal B; Patil V; Somasundaram K
Clin Epigenetics; 2017; 9():32. PubMed ID: 28392842
[TBL] [Abstract][Full Text] [Related]
31. Imaging of Central Nervous System Tumors Based on the 2016 World Health Organization Classification.
Ly KI; Wen PY; Huang RY
Neurol Clin; 2020 Feb; 38(1):95-113. PubMed ID: 31761063
[TBL] [Abstract][Full Text] [Related]
32. Shedding Light on the 2016 World Health Organization Classification of Tumors of the Central Nervous System in the Era of Radiomics and Radiogenomics.
Colen RR; Hassan I; Elshafeey N; Zinn PO
Magn Reson Imaging Clin N Am; 2016 Nov; 24(4):741-749. PubMed ID: 27742114
[TBL] [Abstract][Full Text] [Related]
33. [Update on the 2016 WHO classification of tumors of the central nervous system.Part 2: Embryonal tumors and other tumor groups (except for diffuse gliomas)].
Zámečník J; Rychlý B; Švajdler M
Cesk Patol; 2017; 53(1):22-28. PubMed ID: 28248118
[TBL] [Abstract][Full Text] [Related]
34. Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery.
Cimino PJ; Zager M; McFerrin L; Wirsching HG; Bolouri H; Hentschel B; von Deimling A; Jones D; Reifenberger G; Weller M; Holland EC
Acta Neuropathol Commun; 2017 May; 5(1):39. PubMed ID: 28532485
[TBL] [Abstract][Full Text] [Related]
35. Surgical neuropathology update: a review of changes introduced by the WHO classification of tumours of the central nervous system, 4th edition.
Brat DJ; Parisi JE; Kleinschmidt-DeMasters BK; Yachnis AT; Montine TJ; Boyer PJ; Powell SZ; Prayson RA; McLendon RE;
Arch Pathol Lab Med; 2008 Jun; 132(6):993-1007. PubMed ID: 18517285
[TBL] [Abstract][Full Text] [Related]
36. Clinical implications of the 2021 edition of the WHO classification of central nervous system tumours.
Horbinski C; Berger T; Packer RJ; Wen PY
Nat Rev Neurol; 2022 Sep; 18(9):515-529. PubMed ID: 35729337
[TBL] [Abstract][Full Text] [Related]
37. World Health Organization 2016 Classification of Central Nervous System Tumors.
Diamandis P; Aldape K
Neurol Clin; 2018 Aug; 36(3):439-447. PubMed ID: 30072064
[TBL] [Abstract][Full Text] [Related]
38. cIMPACT-NOW: a practical summary of diagnostic points from Round 1 updates.
Louis DN; Ellison DW; Brat DJ; Aldape K; Capper D; Hawkins C; Paulus W; Perry A; Reifenberger G; Figarella-Branger D; von Deimling A; Wesseling P
Brain Pathol; 2019 Jul; 29(4):469-472. PubMed ID: 31038238
[TBL] [Abstract][Full Text] [Related]
39. [Brain Tumor].
Komori T
Brain Nerve; 2020 Apr; 72(4):399-405. PubMed ID: 32284464
[TBL] [Abstract][Full Text] [Related]
40. [WHO classification of tumours of the CNS: revised edition of 2007 with critical comments on the typing und grading of common-type diffuse gliomas].
Feiden S; Feiden W
Pathologe; 2008 Nov; 29(6):411-21. PubMed ID: 18820922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
